View in browser GARD®skin is now included in OECD TG 497 We are excited to announce that the GARD®skin assay (OECD TG 442E) is now included in OECD TG 497’s Defined Approaches for Skin Sensitization (DASS), bringing high performance and extended applicability to the DASS framework. The assay is part of two key Defined Approaches:  The "2 out of 3" DA for hazard identification The Integrated Testing Strategy (ITS) for hazard identification and potency subcategorization (1A, 1B, NC). Learn more about how GARDskin fits into TG 497. Webcast: How GARD®skin enhances Defined Approaches for Skin Sensitization Watch the webcast to learn what the inclusion of GARD®skin in OECD TG 497 means in practice - and how it can support your regulatory testing strategy. The webcast is now available on demand. WATCH THE RECORDING FDA shift highlights need for innovative, human-relevant test methods The FDA’s recent decision to phase out mandatory animal testing in drug development marks a major regulatory step toward wider adoption of human-relevant, non-animal methods. For SenzaGen, this shift highlights the growing value of technologies like machine learning, genomics, and organoid-based testing.  Read more in the full FDA article Expanded collaboration with RIFM to advance fragrance safety Our long-standing collaboration with the Research Institute for Fragrance Materials (RIFM) continues to grow, driven by a shared commitment to non-animal methods and scientific excellence. Recent projects expand the scope of our work, including new in vitro studies in areas such as photosensitization.  Learn more about our work with RIFM Upcoming events 🌎 World Congress 13 | Rio de Janeiro, Brazil | Aug 31-Sep 4 🌎 Eurotox 2025 | Athens, Greece | Sep 14-17 🌎 ICT 2025 | Beijing, China | Oct 15-18 🌎 ASCCT 2025 | Gaithersburg, USA | Oct 21-23 Copyright © SenzaGen 2025. All rights reserved. SenzaGen AB | Medicon Village | 223 81 Lund, Sweden SenzaGen Group | SenzaGen | VitroScreen | Toxhub You previously opted in or expressed interest in receiving information from SenzaGen. To stop receiving future updates, you can unsubscribe here.